Fu-Ju Chou

956 total citations
22 papers, 682 citations indexed

About

Fu-Ju Chou is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Fu-Ju Chou has authored 22 papers receiving a total of 682 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 13 papers in Molecular Biology and 8 papers in Cancer Research. Recurrent topics in Fu-Ju Chou's work include Prostate Cancer Treatment and Research (10 papers), Cancer-related molecular mechanisms research (4 papers) and PARP inhibition in cancer therapy (4 papers). Fu-Ju Chou is often cited by papers focused on Prostate Cancer Treatment and Research (10 papers), Cancer-related molecular mechanisms research (4 papers) and PARP inhibition in cancer therapy (4 papers). Fu-Ju Chou collaborates with scholars based in United States, China and Taiwan. Fu-Ju Chou's co-authors include Shuyuan Yeh, Chawnshang Chang, Fengchao Lang, Chunzhang Yang, Yang Liu, Chi‐Ping Huang, Bosen You, Jie Luo, Yang Liu and Kareem A. Zaghloul and has published in prestigious journals such as PLoS ONE, Oncogene and Clinical Cancer Research.

In The Last Decade

Fu-Ju Chou

22 papers receiving 676 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fu-Ju Chou United States 17 356 233 228 116 87 22 682
Sachindra Raj Joshi United States 16 330 0.9× 190 0.8× 334 1.5× 56 0.5× 42 0.5× 35 769
Kuo Yang China 19 497 1.4× 263 1.1× 219 1.0× 152 1.3× 31 0.4× 52 825
Simeng Wen China 17 559 1.6× 407 1.7× 310 1.4× 224 1.9× 50 0.6× 30 933
Yuanjun Jiang China 18 365 1.0× 175 0.8× 111 0.5× 117 1.0× 34 0.4× 47 734
Chiara Busletta Italy 9 356 1.0× 283 1.2× 86 0.4× 226 1.9× 69 0.8× 15 940
Timothy G. Whitsett United States 18 527 1.5× 266 1.1× 239 1.0× 247 2.1× 102 1.2× 35 996
Juan M. Jiménez‐Vacas Spain 16 461 1.3× 230 1.0× 181 0.8× 97 0.8× 29 0.3× 32 712
Matthew P. Fitzgerald United States 15 477 1.3× 179 0.8× 166 0.7× 126 1.1× 23 0.3× 21 788
Ju Mei China 19 520 1.5× 314 1.3× 160 0.7× 117 1.0× 41 0.5× 37 750
Yuxiao Zheng China 14 371 1.0× 283 1.2× 193 0.8× 150 1.3× 22 0.3× 57 730

Countries citing papers authored by Fu-Ju Chou

Since Specialization
Citations

This map shows the geographic impact of Fu-Ju Chou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fu-Ju Chou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fu-Ju Chou more than expected).

Fields of papers citing papers by Fu-Ju Chou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fu-Ju Chou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fu-Ju Chou. The network helps show where Fu-Ju Chou may publish in the future.

Co-authorship network of co-authors of Fu-Ju Chou

This figure shows the co-authorship network connecting the top 25 collaborators of Fu-Ju Chou. A scholar is included among the top collaborators of Fu-Ju Chou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fu-Ju Chou. Fu-Ju Chou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yang, Fu-Ju Chou, Fengchao Lang, et al.. (2023). Protein Kinase B (PKB/AKT) Protects IDH-Mutated Glioma from Ferroptosis via Nrf2. Clinical Cancer Research. 29(7). 1305–1316. 23 indexed citations
2.
Liu, Qing, Bosen You, Jialin Meng, et al.. (2022). Targeting the androgen receptor to enhance NK cell killing efficacy in bladder cancer by modulating ADAR2/circ_0001005/PD-L1 signaling. Cancer Gene Therapy. 29(12). 1988–2000. 36 indexed citations
3.
Chou, Fu-Ju, Yuhchyau Chen, Chi‐Ping Huang, et al.. (2022). Targeting the radiation-induced ARv7-mediated circNHS/miR-512-5p/XRCC5 signaling with Quercetin increases prostate cancer radiosensitivity. Journal of Experimental & Clinical Cancer Research. 41(1). 235–235. 15 indexed citations
4.
Chou, Fu-Ju, Yang Liu, Fengchao Lang, & Chunzhang Yang. (2021). D-2-Hydroxyglutarate in Glioma Biology. Cells. 10(9). 2345–2345. 48 indexed citations
5.
You, Bosen, Yin Sun, Jie Luo, et al.. (2021). Androgen receptor promotes renal cell carcinoma (RCC) vasculogenic mimicry (VM) via altering TWIST1 nonsense-mediated decay through lncRNA-TANAR. Oncogene. 40(9). 1674–1689. 42 indexed citations
6.
Tian, Hao, Fu-Ju Chou, Jing Tian, et al.. (2021). ASC-J9® suppresses prostate cancer cell proliferation and invasion via altering the ATF3-PTK2 signaling. Journal of Experimental & Clinical Cancer Research. 40(1). 3–3. 9 indexed citations
7.
Lang, Fengchao, Yang Liu, Fu-Ju Chou, & Chunzhang Yang. (2021). Genotoxic therapy and resistance mechanism in gliomas. Pharmacology & Therapeutics. 228. 107922–107922. 78 indexed citations
8.
Liu, Yang, Fengchao Lang, Fu-Ju Chou, Kareem A. Zaghloul, & Chunzhang Yang. (2020). Isocitrate Dehydrogenase Mutations in Glioma: Genetics, Biochemistry, and Clinical Indications. Biomedicines. 8(9). 294–294. 49 indexed citations
9.
Chou, Fu-Ju, Yuhchyau Chen, Hao Tian, et al.. (2020). Targeting the radiation-induced TR4 nuclear receptor-mediated QKI/circZEB1/miR-141-3p/ZEB1 signaling increases prostate cancer radiosensitivity. Cancer Letters. 495. 100–111. 27 indexed citations
10.
11.
Zhao, Jie, Yin Sun, Hui Lin, et al.. (2020). Olaparib and enzalutamide synergistically suppress HCC progression via the AR‐mediated miR‐146a‐5p/BRCA1 signaling. The FASEB Journal. 34(4). 5877–5891. 17 indexed citations
12.
13.
14.
15.
Zhu, Wei, Zhijian Zhao, Fu-Ju Chou, et al.. (2019). The Protective Roles of Estrogen Receptor β in Renal Calcium Oxalate Crystal Formation via Reducing the Liver Oxalate Biosynthesis and Renal Oxidative Stress-Mediated Cell Injury. Oxidative Medicine and Cellular Longevity. 2019. 1–17. 28 indexed citations
16.
Luo, Jie, Jing Tian, Fu-Ju Chou, et al.. (2018). Targeting the androgen receptor (AR) with AR degradation enhancer ASC-J9® led to increase docetaxel sensitivity via suppressing the p21 expression. Cancer Letters. 444. 35–44. 20 indexed citations
17.
Chou, Fu-Ju, Keliang Wang, Rachel Yang, et al.. (2017). Androgen receptor (AR) degradation enhancer ASC-J9 ® in an FDA-approved formulated solution suppresses castration resistant prostate cancer cell growth. Cancer Letters. 417. 182–191. 38 indexed citations
18.
19.
Yeh, Chiuan‐Ren, Spencer Slavin, Jun Da, et al.. (2016). Estrogen receptor α in cancer associated fibroblasts suppresses prostate cancer invasion via reducing CCL5, IL6 and macrophage infiltration in the tumor microenvironment. Molecular Cancer. 15(1). 7–7. 59 indexed citations
20.
Hong, Jin‐Bon, Fu-Ju Chou, Amy T. Ku, et al.. (2014). A Nucleolus-Predominant piggyBac Transposase, NP-mPB, Mediates Elevated Transposition Efficiency in Mammalian Cells. PLoS ONE. 9(2). e89396–e89396. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sachindra Raj Joshi Breakdown of academic impact, for papers by Kuo Yang Breakdown of academic impact, for papers by Simeng Wen Breakdown of academic impact, for papers by Yuanjun Jiang Breakdown of academic impact, for papers by Chiara Busletta Breakdown of academic impact, for papers by Timothy G. Whitsett Breakdown of academic impact, for papers by Juan M. Jiménez‐Vacas Breakdown of academic impact, for papers by Matthew P. Fitzgerald Breakdown of academic impact, for papers by Ju Mei Breakdown of academic impact, for papers by Yuxiao Zheng
Rankless by CCL
2026